Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy.
Journal: European urology oncology
Published: April 16, 2025
Major adverse cardiovascular events among Black and White Veterans receiving androgen deprivation therapy for prostate cancer: a retrospective cohort study.
Journal: Cardio-oncology (London, England)
Published: October 14, 2024
Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer.
Journal: European urology
Published: February 03, 2024
Moderately Hypofractionated Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Prostate Cancer: Five-Year Toxicity Results From a Prospective Phase I/II Trial.
Journal: Frontiers in oncology
Published: June 18, 2020
Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs.
Journal: Brachytherapy
Published: May 15, 2019
Late toxicity in long-term survivors from a phase 2 study of concurrent radiation therapy, temozolomide and valproic acid for newly diagnosed glioblastoma.
Journal: Neuro-oncology practice
Published: November 08, 2018
Phase 1/2 study of hypofractionated intensity-modulated radiation therapy for prostate cancer including simultaneously integrated boost.
Journal: Practical radiation oncology
Published: May 24, 2017
Lovastatin may reduce the risk of erectile dysfunction following radiation therapy for prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 02, 2016
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.
Journal: American journal of clinical oncology
Published: July 21, 2016
A Systems Engineering and Decision-Support Tool to Enhance Care of Veterans Diagnosed With Prostate Cancer.
Journal: Federal practitioner : for the health care professionals of the VA, DoD, and PHS
Published: February 01, 2016
A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.
Journal: International journal of radiation oncology, biology, physics
Published: January 21, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026